Showing results (1971-1980 of 3,582) with videos related to
Sort By:
Pageof 359
Clinical Pharmacology and Therapeutics|December 1, 1978
Potential anticoagulant drug interactions in ambulatory patientsJ H Hull, W J Murray, H S Brown, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 4, 1998
Evaluation of the developmental toxicity of caffeine and caffeine metabolites using the frog embryo teratogenesis assay--Xenopus (FETAX)D J Fort, E L Stover, T L Propst, et al.Medical Education|April 17, 2008
Differences in the perceived impact of sleep deprivation among surgical and non-surgical residentsSarah I Woodrow, Jason Park, Brian J Murray, et al.Anesthesiology|December 13, 2007
Performance of residents and anesthesiologists in a simulation-based skill assessmentDavid J Murray, John R Boulet, Michael Avidan, et al.Journal of the American Veterinary Medical Association|June 5, 2007
Effects of short-term light to heavy exercise on gastric ulcer development in horses and efficacy of omeprazole paste in preventing gastric ulcerationGary White, Scott R McClure, Roger Sifferman, et al.Journal of Contaminant Hydrology|May 14, 2013
Establishing a geochemical heterogeneity model for a contaminated vadose zone--aquifer systemChristopher J Murray, John M Zachara, James P McKinley, et al.Pediatric Blood & Cancer|May 2, 2013
Acute care of pediatric patients with sickle cell disease: a simulation performance assessmentTracy L Burns, Michael R DeBaun, John R Boulet, et al.Structure (London, England : 1993)|October 15, 1993
Topological similarities in TGF-beta 2, PDGF-BB and NGF define a superfamily of polypeptide growth factorsJ Murray-Rust, N Q McDonald, T L Blundell, et al.Rapid Communications in Mass Spectrometry : RCM|January 30, 2010
Movement of newly assimilated 13C carbon in the grass Lolium perenne and its incorporation into rhizosphere microbial DNAS J Clayton, C D Clegg, A W Bristow, et al.Neurology|August 19, 2007
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?M G Brown, S Kirby, C Skedgel, et al.Pageof 359